Your Advisors
Don Miller
Don'S LATEST HEADLINES
-
Best Investments: The One Stock to Buy in the Red-Hot Biotech Sector
For the best investments to add a little high-potential punch to your portfolio, nothing's better than biotech.
The iShares Nasdaq Biotechnology Exchange Traded Fund (ETF) (Nasdaq: IBB) rose 30.2% in the last 12 months and is already up a healthy 16.5% year to date.
In fact, the biotech sector has been a consistent performer for investors. The Nasdaq Biotechnology Index has notched 16.1% annualized returns for the last five years.
Big gains from just three stocks — Amgen Inc. (Nasdaq: AMGN), BiogenIdec Inc. (Nasdaq: BIIB) and Gilead Sciences Inc. (Nasdaq: GILD) — created a whopping $60 billion in combined shareholder gains in 2012.
And analysts expect the trend to continue.
To continue reading, please click here... - Jim Rogers on the Best Investments to Make When "Everything Has Problems"
- Stocks to Buy: Time to Pull the Trigger on These Three Winners
- Stocks to Buy: Three Small Cap Stocks for Safety & Dividend Growth
- Investing in MLPs: Three Set to Soar on Shale Expansion
- Government S&P Lawsuit: Who's Next?
- Dividend Stocks to Buy Now: The Only New "Aristocrat" Worth a Bet
- Two Ways to Go Big on Gold Stocks Right Now
- Stocks To Buy Now: Profit from Blockbuster New Drugs in 2013
- Three Stocks to Buy in Next Year's Most Promising Sectors